Merck Sharp & Dohme Corp. v. MSN Pharmaceuticals Inc. et al
| Merck Sharp & Dohme Corp. |
| MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited |
| 1:2021cv01172 |
| August 12, 2021 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 17, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 8 WAIVER OF SERVICE returned executed by Merck Sharp & Dohme Corp.: For MSN Pharmaceuticals Inc. waiver sent on 9/13/2021, answer due 11/12/2021. (Joyce, Alexandra) |
| Filing 7 WAIVER OF SERVICE returned executed by Merck Sharp & Dohme Corp.: For MSN Laboratories Private Limited waiver sent on 9/13/2021, answer due 11/12/2021. (Joyce, Alexandra) |
| Filing 6 MOTION for Pro Hac Vice Appearance of Attorney David M. Krinsky - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Certification for David M. Krinsky)(Silver, Daniel) |
SO ORDERED, re (185 in 19-cv-319-RGA; 73 in 20-cv-815-RGA; 12 in 21-cv-824-RGA; 48 in 20-cv-1496-RGA; 156 in 19-cv-314-RGA; 572 in 19-md-2902-RGA; 104 in 20-cv-949-RGA; 6 in 21-cv-1172-RGA; 91 in 20-cv-847-RGA; 114 in 20-cv-749-RGA; 35 in 21-cv-315-RGA; 109 in 20-cv-1099-RGA; 167 in 19-cv-312-RGA; 8 in 21-cv-1173-RGA; 177 in 19-cv-313-RGA) MOTION for Pro Hac Vice Appearance of Attorney David M. Krinsky, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 9/8/2021. Associated Cases: 1:19-cv-00312-RGA et al.(nms)
|
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:21-cv-01172-RGA, 1:21-cv-01173-RGA (rjb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp.. (twk) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (twk) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No Earlier than June 30, 2021. Date of Expiration of Patent: November 24, 2026 (May 24, 2027 pediatric exclusivity expiration). Thirty Month Stay Deadline: No Earlier than 12/30/2023. (twk) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
| Filing 1 COMPLAINT filed against MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3677733.) - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(twk) |
| No Summons Issued. (twk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
